A fully integrated holistic nutrition company offering end-to-end solutions across the value chain and a market
leader in customized micronutrient formulations.
Recognized wellness and clinical nutrition brand in the market.
Long Standing Relationships with our customers.
Established R&D capabilities with focus on innovation.
Manufacturing capabilities of products with quality and food safety procedures.
Well established pan India omnichannel distribution with presence across various geographies.
Professional turned entrepreneur promoters with experienced management team.
Track record of growth in financial performance.
The company is significantly dependent on the premix formulation segment for a substantial portion of its
revenues. During the nine month period ended December 31, 2025, Fiscal 2025, Fiscal 2024, and
Fiscal 2023, revenue from the premix formulations segment amounted to Rs. 1,377.26 million, Rs.
1,546.95 million, Rs. 1,333.13 million, and Rs. 1,527.99 million, respectively, contributing 51.47%,
47.61%, 44.78%, and 54.86% of the company revenue from operations for the respective Fiscals. Any adverse
development affecting this segment may has a material adverse effect on its business, financial
condition, and results of operations.
The company is dependent on a limited number of customers for a significant portion of its revenue. During the nine month period ended December 31, 2025, Fiscal 2025, Fiscal 2024, and Fiscal 2023, revenue
from its top 10 customers aggregated to Rs. 1,118.97 million, Rs. 1,490.49 million, Rs. 1,453.69 million,
and Rs. 1,271.29 million, constituting approximately 41.82%, 45.87%, 48.83%, and 45.65% of the company
revenue from operations, respectively. Loss of one or more such customers or a reduction in their
order volumes may adversely affect its business, financial condition, and results of operations.
Reconstruction of a portion of the company Nashik Facility pursuant to past regulatory actions may lead to
temporary production disruptions, operational inefficiencies, and potential revenue impact.
Sale of expired, defective, or non-compliant products, or failures to meet applicable quality standards,
could expose the company to significant liability, damage its reputation, and adversely affect the company business,
results of operations, and financial condition.
The company does not has long-term contracts with its raw material suppliers, and volatility in raw material
prices or adverse sourcing conditions may adversely impact the company operations, profitability, and financial
performance.
The company efforts to introduce new products is dependent on the success of its research and development
initiatives. The company inability to successfully develop and commercialise new products in a timely manner
could adversely impact its business, growth, and financial condition.
The presence of counterfeit and look-alike products, particularly in the domestic market, may harm
the company brand reputation, erode customer trust, and adversely impact its business and financial
performance.
Majority of the company revenue from operations is generated from key states of India, including
Maharashtra, Karnataka, Tamil Nadu and Gujarat which exposes its operations to potential
geographical concentration risks arising from local and regional factors which may adversely affect
the company operations and in turn its business, results of operations and cash flows.
Exposure to cross-border operational, regulatory, and macroeconomic risks across multiple
jurisdictions may materially and adversely affect the company business, cash flows, results of operations, and
future prospects.
Suboptimal capacity utilisation at the company manufacturing facilities may limit operational efficiency and
adversely affect its business and financial condition.
